Robin Gurganus

734 total citations
15 papers, 459 citations indexed

About

Robin Gurganus is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Robin Gurganus has authored 15 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in Robin Gurganus's work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (10 papers) and Urologic and reproductive health conditions (3 papers). Robin Gurganus is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (10 papers) and Urologic and reproductive health conditions (3 papers). Robin Gurganus collaborates with scholars based in United States and Germany. Robin Gurganus's co-authors include Alan W. Partin, Jonathan I. Epstein, Jurgita Sauvageot, Marcia L. Wills, Thomas J. Polascik, Barbara Rogers, Michael K. Haseman, Robert T. Maguire, Michael J. Manyak and Helen Fedor and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Robin Gurganus

15 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin Gurganus United States	9	314	101	74	73	62	15	459
Renato Naito Japan	11	235 0.7×	58 0.6×	112 1.5×	54 0.7×	75 1.2×	50	486
Masakatsu Oishi Japan	9	215 0.7×	101 1.0×	105 1.4×	48 0.7×	25 0.4×	27	374
Inés M. de Torres Spain	15	439 1.4×	140 1.4×	140 1.9×	58 0.8×	94 1.5×	32	576
Young Sun Lee United States	10	370 1.2×	44 0.4×	125 1.7×	95 1.3×	111 1.8×	17	580
E Okajima Japan	11	101 0.3×	32 0.3×	128 1.7×	168 2.3×	51 0.8×	52	417
Jinxian Pu China	15	164 0.5×	22 0.2×	248 3.4×	52 0.7×	144 2.3×	55	512
Alberto Bonetta Italy	10	250 0.8×	22 0.2×	43 0.6×	50 0.7×	60 1.0×	25	383
Kanako Matsuoka Japan	10	134 0.4×	55 0.5×	79 1.1×	30 0.4×	36 0.6×	52	280
Yuzo Minami Japan	11	129 0.4×	25 0.2×	81 1.1×	89 1.2×	50 0.8×	35	373
Donald E. Mahan United States	11	153 0.5×	35 0.3×	124 1.7×	26 0.4×	69 1.1×	18	348

Countries citing papers authored by Robin Gurganus

Since Specialization

Citations

This map shows the geographic impact of Robin Gurganus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Gurganus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Gurganus more than expected).

Fields of papers citing papers by Robin Gurganus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Gurganus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Gurganus. The network helps show where Robin Gurganus may publish in the future.

Co-authorship network of co-authors of Robin Gurganus

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Gurganus. A scholar is included among the top collaborators of Robin Gurganus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Gurganus. Robin Gurganus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Freedland, Stephen J., Michael Carducci, Nils Kroeger, et al.. (2013). A Double-Blind, Randomized, Neoadjuvant Study of the Tissue Effects of POMx Pills in Men with Prostate Cancer Before Radical Prostatectomy. Cancer Prevention Research. 6(10). 1120–1127. 59 indexed citations

2.

Freedland, Stephen J., Michael A. Carducci, Nils Kroeger, et al.. (2012). 174 A PHASE II RANDOMIZED CONTROLLED TRIAL OF POMX VS. PLACEBO PRIOR TO RADICAL PROSTATECTOMY. The Journal of Urology. 187(4S). 1 indexed citations

3.

Armstrong, Andrew J., George J. Netto, Michelle A. Rudek, et al.. (2010). A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer. Clinical Cancer Research. 16(11). 3057–3066. 62 indexed citations

4.

Antonarakis, Emmanuel S., Elisabeth I. Heath, J Walczak, et al.. (2009). Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers. Journal of Clinical Oncology. 27(30). 4986–4993. 47 indexed citations

5.

Partin, Alan W., Leslie A. Mangold, Robin Gurganus, et al.. (2007). 1623: Biological Variation of PCA3 Score in Men Previously Diagnosed with Prostate Cancer. The Journal of Urology. 177(4S). 538–538. 3 indexed citations

6.

Park, Jae Hyun, Lori J. Sokoll, Debra J. Bruzek, et al.. (2003). Comparison of Total Prostate-Specific Antigen and Derivative Levels in a Screening Population of Black, White, and Korean-American Men. 2(3). 173–176. 2 indexed citations

7.

Chan, Derek Y., et al.. (2000). Minilaparotomy radical retropubic prostatectomy: updated technique and results.. PubMed. 18(1). 19–27. 9 indexed citations

8.

Polascik, Thomas J., et al.. (1999). INFLUENCE OF SEXTANT PROSTATE NEEDLE BIOPSY OR SURGERY ON THE DETECTION AND HARVEST OF INTACT CIRCULATING PROSTATE CANCER CELLS. The Journal of Urology. 162(3 Part 1). 749–752. 12 indexed citations

9.

Polascik, Thomas J., Michael J. Manyak, Michael K. Haseman, et al.. (1999). Comparison of clinical staging algorithms and111Indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients. Cancer. 85(7). 1586–1592. 79 indexed citations

10.

Pound, Charles R., et al.. (1999). DIGITAL RECTAL EXAMINATION AND IMAGING STUDIES ARE UNNECESSARY IN MEN WITH UNDETECTABLE PROSTATE SPECIFIC ANTIGEN FOLLOWING RADICAL PROSTATECTOMY. The Journal of Urology. 162(4). 1337–1340. 39 indexed citations

11.

Pound, Charles R., et al.. (1999). DIGITAL RECTAL EXAMINATION AND IMAGING STUDIES ARE UNNECESSARY IN MEN WITH UNDETECTABLE PROSTATE SPECIFIC ANTIGEN FOLLOWING RADICAL PROSTATECTOMY. The Journal of Urology. 1337–1340. 2 indexed citations

12.

Polascik, Thomas J., Michael J. Manyak, Michael K. Haseman, et al.. (1999). Comparison of clinical staging algorithms and 111Indium‐capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients. Cancer. 85(7). 1586–1592. 1 indexed citations

13.

Wills, Marcia L., Jurgita Sauvageot, Alan W. Partin, Robin Gurganus, & Jonathan I. Epstein. (1998). Ability of Sextant Biopsies to Predict Radical Prostatectomy Stage. Urology. 51(5). 759–764. 109 indexed citations

14.

Marshall, Fray F., et al.. (1998). MINILAPAROTOMY RADICAL RETROPUBIC PROSTATECTOMY. The Journal of Urology. 2440–2445. 2 indexed citations

15.

Marshall, Fray F., et al.. (1998). MINILAPAROTOMY RADICAL RETROPUBIC PROSTATECTOMY. The Journal of Urology. 160(6 Part 2). 2440–2445. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact